trending Market Intelligence /marketintelligence/en/news-insights/trending/ohsxxxdosp4xlyljqa7waw2 content esgSubNav
In This List

Cell MedX appoints board member to add medical device experience

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Cell MedX appoints board member to add medical device experience

Carson City, Nev.-based Cell MedX Corp. added George Adams to its board of directors.

Adams was previously CEO of Amorfix Life Sciences, which is known as ProMIS Neurosciences Inc.

The healthcare equipment company said Adams is experienced in bringing medical devices to global markets. Cell MedX develops medical devices for high blood pressure, diabetes and Parkinson's disease.